Total value in 2019: $8,946.43M (301 completed)

Company Financing type Shares, units or warrants (M) Amount raised (US$M)

October - $733.14M

Alimera Sciences Inc. (Atlanta) Stock purchase N/A $1.00
Aslan Pharmaceuticals Ltd. (Singapore) Loan facility N/A $3.00
Aurinia Pharmaceuticals Inc. (Victoria, British Columbia) At-the-market offering 2.34S $15.00
Aytu Bioscience Inc. (Englewood, Colo.) Private placement N/A $10.00
Bioasis Technologies Inc. (Guilford, Conn.) Bridge financing N/A $0.53
Biondvax Pharmaceuticals Ltd. (Jerusalem) Loan agreement N/A $4.40
Briacell Therapeutics Corp. (Berkeley, Calif.) Private placement 8.6S $0.45
Constellation Pharmaceuticals Inc. (Cambridge, Mass.) Private placement 7.64S $65.00
DBV Technologies SA (Montrouge, France; DBVT) Private placement 1.56S $20.68
FSD Pharma Inc. (Toronto) Private placement 45.83S $3.46
Innate Pharma SA (Marseille, France; IPHA) Private placement 4.45S $24.60
Innovent Biologics Inc. (Suzhou, China) Share issue 97S $300.00
Inventiva SA (Daix, France) Shares issue N/A $0.68
Kadmon Holdings Inc. (New York) Share issue 1.4S $22.00
Mesoblast Ltd. (Melbourne, Australia) Institutional Placement 37.5S $50.32
Motif Bio plc (London) Share issue 142.9S $0.73
Nicox SA (Sophia Antipolis, France) Tranched bond financing N/A $4.40
Nordic Nanovector ASA (Oslo, Norway) Private placement 11.02S $26.40
Recce Pharmaceuticals Ltd. (Sydney) Shares issue 26S $4.58
Redhill Biopharma Ltd. (Tel Aviv, Israel) Share subscription N/A $36.30
Rigel Pharmaceuticals Inc. (South San Francisco) Loan agreement N/A $10.00
Salarius Pharmaceuticals Inc. (Houston) Stock purchase 0.21S $1.00
Sorrento Therapeutics Inc. (San Diego) Registered direct offering 10.86S and W for 10.89S $25.00
Tetraphase Pharmaceuticals Inc. (Watertown, Mass.) Registered direct offering N/A $8.00
TLC Co. Ltd. (Taipei, Taiwan) Shares purchase 10.2S $27.30
Tracon Pharmaceuticals Inc. (San Diego) Stock purchase N/A $15.00
Trovagene Inc. (San Diego) Private placement 2.8S $5.00
Vaxil Bio Ltd. (Ness Ziona, Israel) Private placement 18.8S $0.56
Vivoryon Therapeutics AG (Halle, Germany) Rights offering 7.67S $47.75

No Comments